全文获取类型
收费全文 | 156409篇 |
免费 | 10304篇 |
国内免费 | 781篇 |
专业分类
耳鼻咽喉 | 1429篇 |
儿科学 | 3973篇 |
妇产科学 | 2845篇 |
基础医学 | 21053篇 |
口腔科学 | 3686篇 |
临床医学 | 14970篇 |
内科学 | 33701篇 |
皮肤病学 | 2904篇 |
神经病学 | 15085篇 |
特种医学 | 6210篇 |
外国民族医学 | 7篇 |
外科学 | 23382篇 |
综合类 | 1924篇 |
现状与发展 | 2篇 |
一般理论 | 162篇 |
预防医学 | 11460篇 |
眼科学 | 3238篇 |
药学 | 10593篇 |
2篇 | |
中国医学 | 247篇 |
肿瘤学 | 10621篇 |
出版年
2023年 | 831篇 |
2022年 | 1264篇 |
2021年 | 2876篇 |
2020年 | 1995篇 |
2019年 | 2894篇 |
2018年 | 3508篇 |
2017年 | 2728篇 |
2016年 | 3114篇 |
2015年 | 3577篇 |
2014年 | 5120篇 |
2013年 | 6910篇 |
2012年 | 10619篇 |
2011年 | 11250篇 |
2010年 | 6432篇 |
2009年 | 6140篇 |
2008年 | 10360篇 |
2007年 | 11000篇 |
2006年 | 10479篇 |
2005年 | 10725篇 |
2004年 | 10125篇 |
2003年 | 9610篇 |
2002年 | 9039篇 |
2001年 | 1614篇 |
2000年 | 1228篇 |
1999年 | 1720篇 |
1998年 | 2155篇 |
1997年 | 1685篇 |
1996年 | 1464篇 |
1995年 | 1324篇 |
1994年 | 1180篇 |
1993年 | 1137篇 |
1992年 | 885篇 |
1991年 | 883篇 |
1990年 | 699篇 |
1989年 | 678篇 |
1988年 | 626篇 |
1987年 | 630篇 |
1986年 | 568篇 |
1985年 | 584篇 |
1984年 | 686篇 |
1983年 | 580篇 |
1982年 | 783篇 |
1981年 | 710篇 |
1980年 | 620篇 |
1979年 | 388篇 |
1978年 | 389篇 |
1977年 | 418篇 |
1976年 | 352篇 |
1975年 | 304篇 |
1974年 | 257篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
33.
F Elferink W J van der Vijgh W W ten Bokkel Huinink J B Vermorken I Klein B Winograd M K Knobf G Simonetti H E Gall J G McVie 《British journal of cancer》1987,56(4):479-483
Pharmacokinetics of the cis-platin analog ethylenediaminemalonatoplatinum(II) (JM-410) was studied in 28 cycles of 19 patients during the phase I study of this drug. The drug was administered intravenously by short-term (10-60 min) infusion. Doses ranged from 20 to 1,200mg m-2. JM-40 was determined in plasma ultrafiltrate and urine by HPLC. Platinum (Pt) concentrations were determined in plasma, plasma ultrafiltrate, urine and red blood cells by atomic absorption spectrometry up to 5 days after administration of the drug. Ultrafilterable Pt could be determined up to 45 days after the infusion in one patient sampled over such a long period. Pharmacokinetics of JM-40 showed a linear behaviour. The final half-life of total Pt in plasma was 4.1 +/- 0.9 days. The disposition of JM-40 was similar to that of ultrafilterable Pt in respect to t1/2 alpha (10 and 13 min), t1/2 beta (44 and 57 min), volumes of distribution Vc (11 and 121) and Vss (17 and 201), systemic clearance (256 and 223 ml min-1), renal clearance (69 and 73 ml min-1) and metabolic clearance (183 and 154 ml min-1). During the first 6 h 27 +/- 9% of the administered dose was excreted as JM-40. Cumulative platinum excretion in the urine amounted to 29 +/- 13% and 60 +/- 13% over the first 6 h, 24 h and 5 days, respectively. The uptake of platinum in red blood cells was limited, comprising only 0.24 +/- 0.12% of the administered dose. Although JM-40 and carboplatin are structurally closely related, pharmocokinetics and toxicity of JM-40 were more similar to cis-platin than to carboplatin. 相似文献
34.
Peter Kielty 《The British journal of general practice》1983,33(256):744-745
35.
Peter d'Abbs 《Drug and alcohol review》1989,8(1):21-29
The “restricted areas” provisions of the Northern Territory Liquor Act constitute a preventative policy aimed at reducing the effects of alcohol abuse, particularly on Aboriginal communities. Under the provisions, communities can apply to be declared “dry” or semi-restricted with respect to liquor. Since their inception in 1979, the provisions have given rise to continuing controversy. This paper addresses some of the issues associated with the controversy. Patterns of alcohol consumption on “dry”, semi-restricted and unrestricted communities are compared, and the incidence of apprehension for public drunkenness before and after restricted area declarations is examined. The paper also discusses the provisions under which vehicles implicated in acts of illicit “grog-running” are forfeited to the NT Government. It is concluded that the restricted area provisions are associated with reduced levels of alcohol consumption and apprehensions for drunkenness, and are therefore beneficial in outcome. However, it is also argued that at present the provisions are flawed in that, while some aspects serve to promote community control over alcohol consumption, other elements have the effect of undermining community control and responsibility. 相似文献
36.
37.
Peter D. Le Roux David S. Jardine Paul M. Kanev John D. Loeser 《Child's nervous system》1991,7(1):34-39
We reviewed the results of all pediatric patients undergoing intracranial pressure (ICP) monitoring in a 2-year period at our institution. The outcome of patients suffering hypoxia or ischemic injuries (HII) is compared to those suffering non-hypoxic or non-ischemic injuries (NHII). Thirty-four patients had ICP monitors placed during the study period. Inconplete patient information led to the exclusion of 5 patients. An additional 5 patients were excluded because no measures to control ICP were taken after the monitor was placed. Twenty-four patients required treatment for raised ICP (hyperventilation, 24; mannitol, 19; barbiturate coma, 6). Admission Glasgow Coma Score in patients suffering HII (median score 5) and NHII (median score 6) were not significantly different (Mann-Whitney U Test). Only 2 of 8 patients with HII were near-drowning vietims. The remaining 6 had HII from other causes (5 survivors of various forms of asphyxia and 1 of cardiac arrest). All 8 patients had poor outcomes (1 severely disabled; 7 died). The 16 patients with NHII had a variety of diagnoses (6 trauma, 5 encephalitis, 4 bacterial meningitis, 1 diabetic ketoacidosis). Among these, 6 had good outcomes and 10 poor outcomes (2 severely disabled, 2 vegetative, and 6 died). The difference in outcome between patients with NHII and HII is significant at P=0.059 (Fischer Exact test). Patients with NHII may benefit from ICP monitoring. Patients with HII from near-drowning and other causes did not appear to benefit from ICP monitoring and interventions directed at controlling ICP. 相似文献
38.
Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers. 总被引:6,自引:0,他引:6
Thierry Buclin Monica Cosma Rochat Peter Burckhardt Mo?se Azria Martine Attinger 《Journal of bone and mineral research》2002,17(8):1478-1485
Salmon calcitonin (SCT) is a well-tolerated peptide drug with a wide therapeutic margin and is administered parenterally for long-term treatments of bone diseases. Its clinical usefulness would be enhanced by the development of an orally active formulation. In this randomized crossover double-blinded phase I trial, controlled by both a placebo and a parenteral verum, we have tested a new oral formulation of SCT associated with a caprylic acid derivative as carrier. Eight healthy volunteers received single doses of 400, 800, and 1200 microg of SCT orally, a placebo, and a 10-microg (50 IU) SCT intravenous infusion. SCT was reliably absorbed from the oral formulation, with an absolute bioavailability of 0.5-1.4%, depending on the dose. It induced a marked, dose-dependent drop in blood and urine C-terminal telopeptide of type I collagen (CTX), a sensitive and specific bone resorption marker, with the effects of 1200 microg exceeding those of 10 microg intravenously. It also decreased blood calcium and phosphate, and increased the circulating levels of parathyroid hormone (PTH) and, transiently, the urinary excretion of calcium. It was well-tolerated, with some subjects presenting mild and transient nausea, abdominal cramps, diarrheic stools, and headaches. This study shows that oral delivery of SCT is feasible with reproducible absorption and systemic biological efficacy. Such an oral formulation could facilitate the use of SCT in the treatment of osteoporosis and other bone diseases. 相似文献
39.
Michael S Benninger Peter C Appelbaum James C Denneny David J Osguthorpe James A Stankiewicz 《Otolaryngology--head and neck surgery》2002,127(1):7-12
OBJECTIVE: Traditional assessments of the microbial flora associated with acute bacterial rhinosinusitis have relied on maxillary sinus punctures (taps) and culture. These taps are now considered the gold standard for obtaining cultures and are used as the method of identifying bacterial pathogens in antimicrobial trials. Maxillary sinus taps are limited by discomfort to the patients and technical concerns. Because of these factors, the standard of performing taps has limited antibiotic trials and microbial surveillance. Alternatives to maxillary sinus taps have been explored. STUDY DESIGN: We conducted a retrospective, systematic review of the literature from 1950 to 2000 of articles comparing culture techniques in the nose and paranasal sinuses for acute bacterial rhinosinusitis. RESULTS: Nasal cultures have poor correlation to maxillary sinus cultures, whereas there is 60% to 85% concordance between endoscopically guided middle meatal cultures and maxillary sinus cultures. These studies, however, are all limited by small sample sizes and therefore are inadequate to make any concrete recommendations regarding the relative role of endoscopically guided middle meatal cultures as a formal method of pathogen identification in acute bacterial rhinosinusitis. CONCLUSION: A formal prospective study with sufficient sample size to assess the concordance between the microbial flora of the maxillary sinus punctures and middle meatal cultures in acute rhinosinusitis is recommended. 相似文献
40.